Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources

BMC Pharmacology

Volumn 10, Issue , 2010, Pages

  Asami, Yukihiro ^a   Horie, Ryo ^a   Hamamoto, Hiroshi ^a   Sekimizu, Kazuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,5,6,7,3',4',5' HEPTAMETHOXYFLAVONE; ACETONE; FLAVONE DERIVATIVE; NOBILETIN; TANGERETIN; UNCLASSIFIED DRUG; FLAVONOID; PLANT EXTRACT;

ARTICLE; BODY FLUID; DRUG ABSORPTION; DRUG TISSUE LEVEL; HEMOLYMPH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORANGE (FRUIT); SILKWORM; ANIMAL; ANIMAL MODEL; BLOOD; METABOLISM; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BOMBYX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FLAVONES; FLAVONOIDS; HEMOLYMPH; MASS SPECTROMETRY; MODELS, ANIMAL; PLANT EXTRACTS;

EID: 77953312112     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-10-7     Document Type: Article

References (15)

1. Greaves P, Williams A, Eve M. First dose of potential new medicines to humans: how animals help. Nat Rev Drug Discov 2004, 3(3):226-236. 10.1038/nrd1329, 15031736.
2. Rostami-Hodjegan A, Tucker GT. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov 2007, 6(2):140-148. 10.1038/nrd2173, 17268485.
3. Berger J. Preclinical testing on insects predicts human haematotoxic potentials. Lab Anim 2009, 43(4):328-332. 10.1258/la.2008.007162, 19505933.
4. Hamamoto H, Kurokawa K, Kaito C, Kamura K, Manitra Razanajatovo I, Kusuhara H, Santa T, Sekimizu K. Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob Agents Chemother 2004, 48(3):774-779. 10.1128/AAC.48.3.774-779.2004, 353159, 14982763.
5. Hamamoto H, Tonoike A, Narushima K, Horie R, Sekimizu K. Silkworm as a model animal to evaluate drug candidate toxicity and metabolism. Comp Biochem Physiol C Toxicol Pharmacol 2009, 149(3):334-339. 10.1016/j.cbpc.2008.08.008, 18804554.
6. Hamamoto H, Kamura K, Razanajatovo IM, Murakami K, Santa T, Sekimizu K. Effects of molecular mass and hydrophobicity on transport rates through non-specific pathways of the silkworm larva midgut. Int J Antimicrob Agents 2005, 26(1):38-42. 10.1016/j.ijantimicag.2005.03.008, 15963696.
7. Li S, Lo CY, Ho CT. Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. J Agric Food Chem 2006, 54(12):4176-4185. 10.1021/jf060234n, 16756344.
8. Li S, Pan MH, Lai CS, Lo CY, Dushenkov S, Ho CT. Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines. Bioorg Med Chem 2007, 15(10):3381-3389. 10.1016/j.bmc.2007.03.021, 17391969.
9. Li S, Sang S, Pan MH, Lai CS, Lo CY, Yang CS, Ho CT. Anti-inflammatory property of the urinary metabolites of nobiletin in mouse. Bioorg Med Chem Lett 2007, 17(18):5177-5181. 10.1016/j.bmcl.2007.06.096, 17644380.
10. Cholbi MR, Paya M, Alcaraz MJ. Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation. Experientia 1991, 47(2):195-199. 10.1007/BF01945426, 2001725.
11. Sergeev IN, Li S, Colby J, Ho CT, Dushenkov S. Polymethoxylated flavones induce Ca(2+)-mediated apoptosis in breast cancer cells. Life Sci 2006, 80(3):245-253. 10.1016/j.lfs.2006.09.006, 17046027.
12. Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun 2008, 366(1):168-173. 10.1016/j.bbrc.2007.11.100, 18053806.
13. Yasuda T, Yoshimura Y, Yabuki H, Nakazawa T, Ohsawa K, Mimaki Y, Sashida Y. Urinary metabolites of nobiletin orally administered to rats. Chem Pharm Bull (Tokyo) 2003, 51(12):1426-1428. 10.1248/cpb.51.1426, 14646323.
14. Murakami A, Kuwahara S, Takahashi Y, Ito C, Furukawa H, Ju-Ichi M, Koshimizu K. In vitro absorption and metabolism of nobiletin, a chemopreventive polymethoxyflavonoid in citrus fruits. Biosci Biotechnol Biochem 2001, 65(1):194-197. 10.1271/bbb.65.194, 11272829.
15. Nielsen SE, Breinholt V, Cornett C, Dragsted LO. Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus. Food Chem Toxicol 2000, 38(9):739-746. 10.1016/S0278-6915(00)00072-7, 10930694.